Home / Inspections / 1069326

FDA Inspection 1069326 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3007166613

The FDA completed an inspection of Octapharma Plasma, Inc. on September 19, 2018 in Newport News, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newport News, VA (United States)

Facility

Other inspections at this facility

  • 1132304 (NAI Wed Oct 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 970304 (VAI Fri Apr 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865923 (NAI Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 779864 (NAI Thu Apr 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources